INTEC PHARMA LTD JERUSALEM's ticker is and the CUSIP is M53644106. A total of 16 filers reported holding INTEC PHARMA LTD JERUSALEM in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $13,035,000 | -24.4% | 2,962,568 | +8.7% | 2.32% | -17.6% |
| Q1 2018 | $17,231,000 | +22.8% | 2,724,283 | 0.0% | 2.81% | +6.2% |
| Q4 2017 | $14,030,000 | -42.5% | 2,724,283 | 0.0% | 2.65% | -39.4% |
| Q3 2017 | $24,382,000 | +969.4% | 2,724,283 | +581.1% | 4.37% | +584.8% |
| Q2 2017 | $2,280,000 | – | 400,000 | – | 0.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 630,000 | $3,528,000 | 1.74% |
| DAFNA Capital Management LLC | 135,000 | $756,000 | 0.75% |
| Cormorant Asset Management, LP | 800,000 | $4,480,000 | 0.72% |
| Perceptive Advisors | 700,000 | $3,920,000 | 0.16% |
| SABBY MANAGEMENT, LLC | 613,910 | $3,438,000 | 0.14% |
| Ion Asset Management Ltd. | 10,000 | $56,000 | 0.08% |
| JANE STREET GROUP, LLC | 34,317 | $194,000 | 0.00% |
| UBS Group AG | 1,296 | $7,000 | 0.00% |